GSK shares fall after sales of top two vaccines disappoint

[cafead]

via

• Sales for top two vaccines disappoint
• Cuts vaccine outlook, cites US agency decision on RSV
• Shares fall as much as 2.2%
• Raises annual earnings, sales outlook for 2nd time this year
• Factors hitting vaccine sales are short-term: CEO

article source